AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2024
Feb 16, 2024
30016_dirs_2024-02-16_86e09d48-faa1-4e3e-ad90-3d8f0eb18bec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-02-14
Reporting Person: Underberg Sharon E. (EVP, GC & Corporate Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-14 | Common Stock | A | 483 | — | Acquired | 4764.9449 | Direct |
| 2024-02-14 | Common Stock | A | 216 | — | Acquired | 4980.9449 | Direct |
| 2024-02-14 | Common Stock | A | 138 | — | Acquired | 5118.9449 | Direct |
| 2024-02-14 | Common Stock | A | 173 | — | Acquired | 5291.9449 | Direct |
| 2024-02-14 | Common Stock | A | 176 | — | Acquired | 5467.9449 | Direct |
| 2024-02-14 | Common Stock | F | 356 | $560.56 | Disposed | 5111.9449 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-14 | Non-Qualified Stock Option (right-to-buy) | $560.56 | A | 3856 | Acquired | 2034-02-13 | Common Stock (3856) | Direct |
| 2024-02-14 | Incentive Stock Option (right-to-buy) | $560.56 | A | 178 | Acquired | 2034-02-13 | Common Stock (178) | Direct |
| 2024-02-14 | Restricted Stock Unit | $ | A | 870 | Acquired | Common Stock (870) | Direct | |
| 2024-02-14 | Restricted Stock Unit | $ | M | 483 | Disposed | Common Stock (483) | Direct | |
| 2024-02-14 | Restricted Stock Unit | $ | M | 216 | Disposed | Common Stock (216) | Direct | |
| 2024-02-14 | Restricted Stock Unit | $ | M | 138 | Disposed | Common Stock (138) | Direct | |
| 2024-02-14 | Restricted Stock Unit | $ | M | 173 | Disposed | Common Stock (173) | Direct | |
| 2024-02-14 | Restricted Stock Unit | $ | M | 176 | Disposed | Common Stock (176) | Direct |
Footnotes
F1: Includes a total of 37.247 shares purchased under the Issuer Employee Stock Purchase Plan on June 30, 2023, September 29, 2023 and December 29, 2023.
F2: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
F4: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
F5: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020.
F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021.
F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F9: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.